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Globally, Shiga toxin-producing Escherichia coli (STEC) is an important cause of
diarrheal disease, most notably hemorrhagic colitis, and post-diarrheal sequela, such as
hemolytic-uremic syndrome (HUS) [1]. Cattle are a major reservoir of STEC, with approx-
imately half of the cases in humans attributable to foodborne exposure [2]. Prevention
of human illness has mainly been through food safety measures [2]. Despite extensive
research, no other generally accepted and effective preventive measures or therapies for
STEC infections in human patients are available [3]. Many questions remain about STEC
virulence factors, pathogenesis, detection, and other aspects that necessitate a continua-
tion of basic and applied research on a wide front. This Special Issue includes 14 papers
(nine articles, two communications, one review, one comment, and one reply) that col-
lectively provide novel information on the epidemiology [4–7], virulence factors [7–10],
and pathogenesis [11–13] of STEC, and the molecular structure or toxicity [14–16] and
immunodetection [17] of Shiga toxin.
A systematic review of STEC in Brazil found no data for 44% of the Brazilian states,
highlighting the need for expansion of epidemiological monitoring to the entire country
and alignment of food safety standards with that of international bodies [4–6]. Although
STEC O111:H8 remains the leading serotype in Brazil, a diversity of other serotypes,
some carrying virulence genes and belonging to specific sequence types, were isolated from
human patients with bloody diarrhea and HUS, indicating the need for further studies to
determine whether they have epidemiological relevance [7].
Several studies addressing virulence factors provided novel information about how
they influence carriage in reservoir hosts and disease in human patients. A single base
pair A to T transversion, intergenic to the curli divergent operons csgDEFG and csgBAC in
E. coli O157:H7 stably conferred biofilm formation, epithelial cell invasion, and persistence
in cattle [8]. E. coli O45:H2 is a close relative, phylogenetically, to E. coli O103:H2, sharing a
high degree of homology in virulence factors, such as Stx prophages; however, it is distinct
from E. coli O45:H16, suggesting that serotype O45:H2 may share virulence characteristics
of O103:H2, which is frequently associated with severe illness [9]. E. coli O157:H7 secretes
EF-Tu and L-asparaginase II, with the latter inhibiting T-lymphocyte proliferation [10].
OmpT contributes to E. coli O157:H7 adhesion to human epithelial cells [10].
Other studies, using a variety of methods and approaches, extend our knowledge of
the pathogenesis of STEC infections. A comparison of the transcriptomic and phenotypic
responses of host cells infected with STEC O113:H21 strains from a HUS patient or bovine
feces having similar virulence factor profiles, found that the former induced greater and ear-
lier host cell global gene expression with excessive inflammatory and apoptotic responses,
which may explain its enhanced virulence [11]. A study reported on the identification of
Stx2e receptors on porcine kidney epithelial cells, providing the first data on their Stx2e-
mediated damage and suggesting a possible involvement in edema disease of swine [12].
Another study described the first report of E. coli O157:H7 causing attaching–effacing
lesions in the uroepithelium and the first evidence of the utility of the gnotobiotic piglet as
a model for studies of the pathogenesis of STEC-induced urinary tract infections [13].
Studies utilizing top-down proteomic analysis and a protocol for preparation of
outer membrane vesicles (OMVs) provide further new information on Stx, and position
scientists for future studies to address the effects of Stx on cells. Top-down proteomic
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analysis of the B-subunit successfully identified both Stx1a and Stx2a in STEC strains with
results consistent with whole genome sequencing, validating the utility of this analytical
method to distinguish types and subtypes of Stx [14]. A study structurally and functionally
characterized Stx2k, a new subtype of Stx2, providing tools for early detection and control
of STEC producing this less well-known toxin [15]. A protocol for the preparation of
synthetic outer membrane vesicles (OMVs) with a defined lipid composition resembling
the E. coli outer membrane and loading with functional Stx2a was described [16]. The OMVs
were able to deliver Stx2a to host cells in the absence of other confounders of studies of
Stx toxicity found in cell membranes—e.g., lipopolysaccharide. This work makes possible
future studies on the degree of virulence associated with individual toxins from EHEC and
other bacterial pathogens [16].
A study evaluating three immunological diagnostic assays for STEC (latex aggluti-
nation, lateral flow, and capture ELISA) found that all were highly sensitive and specific,
indicating that robust tools for the diagnosis of STEC infections are available [17]. Collec-
tively, the papers in this Special Issue on STEC reveal significant progress in the understand-
ing of these pathogens, but they also highlight their complexity with the realization that
more work is necessary to enable the development of more specific preventive measures
and therapies.
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